Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors
Identifieur interne : 000491 ( PascalFrancis/Checkpoint ); précédent : 000490; suivant : 000492Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors
Auteurs : Han-Zhong Zhang [États-Unis] ; HONG ZHANG [États-Unis] ; William Kemnitzer [États-Unis] ; Ben Tseng [États-Unis] ; Jindrich Jr Cinatl [Allemagne] ; Martin Michaelis [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; SUI XIONG CAI [États-Unis]Source :
- Journal of medicinal chemistry : (Print) [ 0022-2623 ] ; 2006.
Descripteurs français
- Pascal (Inist)
- Synthèse chimique, Dipeptide, Cétone, Syndrome respiratoire aigu sévère, Virus syndrome respiratoire aigu sévère, Antiviral, In vitro, Relation structure activité, Halogénocétone, Composé peptidomimétique, Fluor Composé organique, Peptide, Lignée cellulaire, Singe, Rein, Côlon, Homme, Lignée VERO, Lignée CACO2, Glutamine(N2-benzyloxycarbonylleucyl-1-désoxy-N5,N5-diméthyl-1-fluorométhyl).
- Wicri :
English descriptors
- KwdEn :
Abstract
This paper describes the design and synthesis of dipeptidyl N,N-dimethyl glutaminyl fluoromethyl ketones (fmk) as severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. The compounds were tested against SARS-CoV-induced cell death in Vero or CaCo2 cells as a measurement of the inhibiting effects of the compounds on the replication of the virus. Z-Leu-Gln(NMe2)-fmk (6a) was found to be a potent inhibitor with low toxicity in cells, protecting cells with an EC50 value of 2.5 μM and exhibiting a selectivity index of >40.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:06-0304982Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors</title>
<author><name sortKey="Zhang, Han Zhong" sort="Zhang, Han Zhong" uniqKey="Zhang H" first="Han-Zhong" last="Zhang">Han-Zhong Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hong Zhang" sort="Hong Zhang" uniqKey="Hong Zhang" last="Hong Zhang">HONG ZHANG</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kemnitzer, William" sort="Kemnitzer, William" uniqKey="Kemnitzer W" first="William" last="Kemnitzer">William Kemnitzer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tseng, Ben" sort="Tseng, Ben" uniqKey="Tseng B" first="Ben" last="Tseng">Ben Tseng</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cinatl, Jindrich Jr" sort="Cinatl, Jindrich Jr" uniqKey="Cinatl J" first="Jindrich Jr" last="Cinatl">Jindrich Jr Cinatl</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sui Xiong Cai" sort="Sui Xiong Cai" uniqKey="Sui Xiong Cai" last="Sui Xiong Cai">SUI XIONG CAI</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0304982</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0304982 INIST</idno>
<idno type="RBID">Pascal:06-0304982</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000489</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000501</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000491</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000491</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors</title>
<author><name sortKey="Zhang, Han Zhong" sort="Zhang, Han Zhong" uniqKey="Zhang H" first="Han-Zhong" last="Zhang">Han-Zhong Zhang</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hong Zhang" sort="Hong Zhang" uniqKey="Hong Zhang" last="Hong Zhang">HONG ZHANG</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kemnitzer, William" sort="Kemnitzer, William" uniqKey="Kemnitzer W" first="William" last="Kemnitzer">William Kemnitzer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tseng, Ben" sort="Tseng, Ben" uniqKey="Tseng B" first="Ben" last="Tseng">Ben Tseng</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cinatl, Jindrich Jr" sort="Cinatl, Jindrich Jr" uniqKey="Cinatl J" first="Jindrich Jr" last="Cinatl">Jindrich Jr Cinatl</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Hesse (Land)</region>
<region type="district" nuts="2">District de Darmstadt</region>
<settlement type="city">Francfort-sur-le-Main</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sui Xiong Cai" sort="Sui Xiong Cai" uniqKey="Sui Xiong Cai" last="Sui Xiong Cai">SUI XIONG CAI</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>San Diego, California 92121</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of medicinal chemistry : (Print)</title>
<title level="j" type="abbreviated">J. med. chem. : (Print)</title>
<idno type="ISSN">0022-2623</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral</term>
<term>Cell line</term>
<term>Chemical synthesis</term>
<term>Colon</term>
<term>Dipeptides</term>
<term>Fluorine Organic compounds</term>
<term>Haloketone</term>
<term>Human</term>
<term>In vitro</term>
<term>Ketone</term>
<term>Kidney</term>
<term>Monkey</term>
<term>Peptides</term>
<term>Peptidomimetic compound</term>
<term>Severe acute respiratory syndrome</term>
<term>Severe acute respiratory syndrome virus</term>
<term>Structure activity relation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Synthèse chimique</term>
<term>Dipeptide</term>
<term>Cétone</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus syndrome respiratoire aigu sévère</term>
<term>Antiviral</term>
<term>In vitro</term>
<term>Relation structure activité</term>
<term>Halogénocétone</term>
<term>Composé peptidomimétique</term>
<term>Fluor Composé organique</term>
<term>Peptide</term>
<term>Lignée cellulaire</term>
<term>Singe</term>
<term>Rein</term>
<term>Côlon</term>
<term>Homme</term>
<term>Lignée VERO</term>
<term>Lignée CACO2</term>
<term>Glutamine(N2-benzyloxycarbonylleucyl-1-désoxy-N5,N5-diméthyl-1-fluorométhyl)</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Singe</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This paper describes the design and synthesis of dipeptidyl N,N-dimethyl glutaminyl fluoromethyl ketones (fmk) as severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. The compounds were tested against SARS-CoV-induced cell death in Vero or CaCo2 cells as a measurement of the inhibiting effects of the compounds on the replication of the virus. Z-Leu-Gln(NMe<sub>2</sub>
)-fmk (6a) was found to be a potent inhibitor with low toxicity in cells, protecting cells with an EC<sub>50</sub>
value of 2.5 μM and exhibiting a selectivity index of >40.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0022-2623</s0>
</fA01>
<fA02 i1="01"><s0>JMCMAR</s0>
</fA02>
<fA03 i2="1"><s0>J. med. chem. : (Print)</s0>
</fA03>
<fA05><s2>49</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ZHANG (Han-Zhong)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>HONG ZHANG</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>KEMNITZER (William)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>TSENG (Ben)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>CINATL (Jindrich JR)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>MICHAELIS (Martin)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>DOERR (Hans Wilhelm)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>SUI XIONG CAI</s1>
</fA11>
<fA14 i1="01"><s1>Maxim Pharmaceuticals, 6650 Nancy Ridge Drive</s1>
<s2>San Diego, California 92121</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Institute for Medical Virology, Clinics of the Johann Wolfgang Goethe-University, Paul-Ehrlich-Strasse 40</s1>
<s2>60596 Frankfurt</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>1198-1201</s1>
</fA20>
<fA21><s1>2006</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>9165</s2>
<s5>354000135730280370</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>22 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0304982</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of medicinal chemistry : (Print)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>This paper describes the design and synthesis of dipeptidyl N,N-dimethyl glutaminyl fluoromethyl ketones (fmk) as severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. The compounds were tested against SARS-CoV-induced cell death in Vero or CaCo2 cells as a measurement of the inhibiting effects of the compounds on the replication of the virus. Z-Leu-Gln(NMe<sub>2</sub>
)-fmk (6a) was found to be a potent inhibitor with low toxicity in cells, protecting cells with an EC<sub>50</sub>
value of 2.5 μM and exhibiting a selectivity index of >40.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02S05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Synthèse chimique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Chemical synthesis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Síntesis química</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Dipeptide</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dipeptides</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Dipéptido</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Cétone</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Ketone</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Cetona</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Virus syndrome respiratoire aigu sévère</s0>
<s2>NW</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Severe acute respiratory syndrome virus</s0>
<s2>NW</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Severe acute respiratory syndrome virus</s0>
<s2>NW</s2>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Antiviral</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Antiviral</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Antiviral</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>In vitro</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>In vitro</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>In vitro</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Relation structure activité</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Structure activity relation</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Relación estructura actividad</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Halogénocétone</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Haloketone</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Halocetona</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Composé peptidomimétique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Peptidomimetic compound</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Compuesto peptidomimético</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Fluor Composé organique</s0>
<s2>NC</s2>
<s2>FX</s2>
<s2>NA</s2>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Fluorine Organic compounds</s0>
<s2>NC</s2>
<s2>FX</s2>
<s2>NA</s2>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Fluor Compuesto orgánico</s0>
<s2>NC</s2>
<s2>FX</s2>
<s2>NA</s2>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Peptide</s0>
<s5>32</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Peptides</s0>
<s5>32</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Péptido</s0>
<s5>32</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Lignée cellulaire</s0>
<s5>33</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Cell line</s0>
<s5>33</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Línea celular</s0>
<s5>33</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Singe</s0>
<s5>34</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Monkey</s0>
<s5>34</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Mono</s0>
<s5>34</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Rein</s0>
<s5>35</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Kidney</s0>
<s5>35</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Riñón</s0>
<s5>35</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Côlon</s0>
<s5>36</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Colon</s0>
<s5>36</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Colón</s0>
<s5>36</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Homme</s0>
<s5>37</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Human</s0>
<s5>37</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Hombre</s0>
<s5>37</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE"><s0>Lignée VERO</s0>
<s4>INC</s4>
<s5>76</s5>
</fC03>
<fC03 i1="19" i2="X" l="FRE"><s0>Lignée CACO2</s0>
<s4>INC</s4>
<s5>77</s5>
</fC03>
<fC03 i1="20" i2="X" l="FRE"><s0>Glutamine(N2-benzyloxycarbonylleucyl-1-désoxy-N5,N5-diméthyl-1-fluorométhyl)</s0>
<s2>NK</s2>
<s4>INC</s4>
<s5>78</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Appareil respiratoire pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>53</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="11" i2="X" l="FRE"><s0>Poumon pathologie</s0>
<s5>54</s5>
</fC07>
<fC07 i1="11" i2="X" l="ENG"><s0>Lung disease</s0>
<s5>54</s5>
</fC07>
<fC07 i1="11" i2="X" l="SPA"><s0>Pulmón patología</s0>
<s5>54</s5>
</fC07>
<fN21><s1>198</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations><list><country><li>Allemagne</li>
<li>États-Unis</li>
</country>
<region><li>District de Darmstadt</li>
<li>Hesse (Land)</li>
</region>
<settlement><li>Francfort-sur-le-Main</li>
</settlement>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Zhang, Han Zhong" sort="Zhang, Han Zhong" uniqKey="Zhang H" first="Han-Zhong" last="Zhang">Han-Zhong Zhang</name>
</noRegion>
<name sortKey="Hong Zhang" sort="Hong Zhang" uniqKey="Hong Zhang" last="Hong Zhang">HONG ZHANG</name>
<name sortKey="Kemnitzer, William" sort="Kemnitzer, William" uniqKey="Kemnitzer W" first="William" last="Kemnitzer">William Kemnitzer</name>
<name sortKey="Sui Xiong Cai" sort="Sui Xiong Cai" uniqKey="Sui Xiong Cai" last="Sui Xiong Cai">SUI XIONG CAI</name>
<name sortKey="Tseng, Ben" sort="Tseng, Ben" uniqKey="Tseng B" first="Ben" last="Tseng">Ben Tseng</name>
</country>
<country name="Allemagne"><region name="Hesse (Land)"><name sortKey="Cinatl, Jindrich Jr" sort="Cinatl, Jindrich Jr" uniqKey="Cinatl J" first="Jindrich Jr" last="Cinatl">Jindrich Jr Cinatl</name>
</region>
<name sortKey="Doerr, Hans Wilhelm" sort="Doerr, Hans Wilhelm" uniqKey="Doerr H" first="Hans Wilhelm" last="Doerr">Hans Wilhelm Doerr</name>
<name sortKey="Michaelis, Martin" sort="Michaelis, Martin" uniqKey="Michaelis M" first="Martin" last="Michaelis">Martin Michaelis</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000491 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000491 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PascalFrancis |étape= Checkpoint |type= RBID |clé= Pascal:06-0304982 |texte= Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |